CellSight Technologies Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
CellSight Technologies is a privately held biotechnology company specializing in molecular imaging with PET to develop imaging companion diagnostics for therapy development and clinical management. It is based in San Francisco, California, and operates with a small, specialized team. The company aims to enable earlier assessment of therapeutic efficacy by visualizing relevant biological processes in living subjects. It has received eIND approvals for two imaging approaches: a probe that visualizes activated T cells without altering them and a reporter-gene/PET probe system for monitoring engineered cells. In its market, the company targets pharmaceutical and biotech developers of immuno-oncology therapies as well as clinicians who rely on imaging to guide treatment decisions. It has pursued collaborations with industry players to evaluate its imaging tracers, including partnerships with Boehringer Ingelheim and Telix Pharmaceuticals.